Skip to content

EFFECTS OF VİRTUAL REALİTY AND MOBİLE PHONE-BASED DİSTRACTİON ON PAİN AND ANXİETY DURİNG BURN DRESSİNG CHANGES: A RANDOMİZED CONTROLLED TRİAL

EFFECTS OF VİRTUAL REALİTY AND MOBİLE PHONE-BASED DİSTRACTİON ON PAİN AND ANXİETY DURİNG BURN DRESSİNG CHANGES: A RANDOMİZED CONTROLLED TRİAL

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07507448
Enrollment
99
Registered
2026-04-02
Start date
2026-03-30
Completion date
2026-05-01
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns Degree Second

Keywords

Virtual Reality, Smartphone, Burn Dressing, Pain Management, Anxiety Management, Non-Pharmacological Intervention

Brief summary

This randomized controlled trial aims to evaluate the effects of virtual reality (VR) and smartphone-based distraction methods on pain and anxiety during dressing changes in outpatients with burns. A total of 99 patients, with 33 in each group, will be randomly assigned to VR, smartphone, or control groups. Pain and anxiety will be assessed immediately after dressing using the Visual Analog Scale (VAS) and Burn-Specific Pain Anxiety Scale (BSPAS). The study is expected to provide evidence on non-pharmacological distraction methods that may improve patient comfort during burn care.

Detailed description

This study will recruit 99 outpatients attending a hospital burn center, with 33 patients in each group. Participants will be randomly assigned to one of three groups: VR, smartphone, or control. VR Group: Patients will receive standard visual and auditory content via a VR headset during dressing changes. Smartphone Group: Patients will use self-selected visual and auditory content on their personal smartphones during dressing changes. Control Group: Patients will receive standard burn care without any distraction intervention. Pain and anxiety will be measured immediately after the dressing procedure using the Visual Analog Scale (VAS) and Burn-Specific Pain Anxiety Scale (BSPAS).

Interventions

BEHAVIORALVR

Participants will receive standard visual and auditory content via a VR headset during burn dressing changes. The intervention aims to distract patients from pain and anxiety. Pain and anxiety will be assessed immediately after the procedure using the Visual Analog Scale (VAS) and Burn-Specific Pain Anxiety Scale (BSPAS).

BEHAVIORALSmartphone Distraction

Participants will use self-selected visual and auditory content on their personal smartphones during burn dressing changes to reduce pain and anxiety. Pain and anxiety will be measured immediately after the procedure using VAS and BSPAS.

Sponsors

Senem Andı
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients aged 18-65 years presenting to the burn outpatient clinic for dressing changes, Patients with second-degree burns involving ≤15% total body surface area (TBSA), Patients who are able to communicate verbally and in writing, Patients who have not used any pharmacological or non-pharmacological interventions that may affect pain within the last 24 hours, Patients who provide informed consent to participate in the study.

Exclusion criteria

* Patients with cognitive, auditory, or visual impairments that may interfere with study participation, Patients with burns located on the face or head that may prevent the use of VR equipment, Patients with any condition that may affect pain perception or the ability to complete study procedures.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS)Immediately after the dressing procedurePain intensity measured by Visual Analog Scale (VAS)
Burn-Specific Pain Anxiety Scale (BSPAS)Immediately after the dressing procedureAnxiety level measured by Burn-Specific Pain Anxiety Scale (BSPAS)

Contacts

CONTACTSenem Andı, PhD
senemperktas@gmail.com+905077257047

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026